Access to anti-retroviral drugs, male in World
World: Access to anti-retroviral drugs, male was 73.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, male in World, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, male in World stood at 73.0%. That is the highest value across all 25 years on record.
The figure is up 4.3% on the previous year and up 92.1% over ten years.
Over the whole period, access to anti-retroviral drugs, male in World peaked at 73.0% in 2024 and was at its lowest, 2.0%, in 2000.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, male in World, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 2.0% | — |
| 2001 | 2.0% | +0.0% |
| 2002 | 3.0% | +50.0% |
| 2003 | 3.0% | +0.0% |
| 2004 | 4.0% | +33.3% |
| 2005 | 6.0% | +50.0% |
| 2006 | 8.0% | +33.3% |
| 2007 | 11.0% | +37.5% |
| 2008 | 14.0% | +27.3% |
| 2009 | 18.0% | +28.6% |
| 2010 | 24.0% | +33.3% |
| 2011 | 27.0% | +12.5% |
| 2012 | 30.0% | +11.1% |
| 2013 | 34.0% | +13.3% |
| 2014 | 38.0% | +11.8% |
| 2015 | 42.0% | +10.5% |
| 2016 | 46.0% | +9.5% |
| 2017 | 51.0% | +10.9% |
| 2018 | 55.0% | +7.8% |
| 2019 | 59.0% | +7.3% |
| 2020 | 62.0% | +5.1% |
| 2021 | 65.0% | +4.8% |
| 2022 | 68.0% | +4.6% |
| 2023 | 70.0% | +2.9% |
| 2024 | 73.0% | +4.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 7.1% | 2.0% | 18.0% | 10 |
| 2010s | 40.6% | 24.0% | 59.0% | 10 |
| 2020s | 67.6% | 62.0% | 73.0% | 5 |
Countries ranked near World
More gender data for World
- Child population (UN estimates and projections) 1.96 million (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.4902 % change on previous year (2030)
- Population 6.61 million (2030)
- Working-age population (UN estimates and projections) 6.61 million (2030)
- Population (UN estimates and projections), annual growth rate 1.16 % change on previous year (2030)
- Inactivity rate (ILO modelled estimates) 39.48 (2027)
- Prevalence of obesity, female 15.1% (2016)
- Prevalence of obesity, male 11.1% (2016)
- Child population (UN estimates and projections) (0-14), per capita 0.0002 units per person (2025)
- Population (UN estimates and projections), per capita 0.0008 units per person (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in World?
- Access to anti-retroviral drugs, male in World was 73.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in World?
- The highest recorded value was 73.0% in 2024.
- What is the lowest access to anti-retroviral drugs, male recorded in World?
- The lowest recorded value was 2.0% in 2000.
- How does World rank for access to anti-retroviral drugs, male?
- World ranks 15th out of 19 groups with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in World?
- Over the last ten years it is up 92.1%. The long-run trend across the full record is volatile.
- Where does this World data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.